Ads
related to: cancer drug
Search results
Cancer Drug Price-Cutting Pitch Mulled by HHS as Industry Waits
Bloomberg Law· 14 hours agoThe Biden administration is weighing a drug pricing control proposition that attorneys and industry watchers say could bolster efforts to lower prescription costs even if ...
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Boston Herald· 5 hours agoWhen doctors began using the drug sotorasib in 2021 with high expectations for its innovative...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 1 day agoTrulicity, another diabetes treatment, had $1.46 billion in first-quarter sales, down 26% and below...
Pfizer agrees to settle 10K Zantac lawsuits, as GSK trial links heartburn drug to cancer
BenefitsPRO· 1 day agoPfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its...
JD Supra: FDA Approves New Indication for AstraZeneca and Daiichi Sankyo’s Cancer Drug ENHERTU
JD Supra· 5 hours agoENHERTU, which is now FDA-approved for five indications, is a specifically engineered HER2-directed antibody drug conjugate (“ADC”) discovered by Daiichi Sankyo and jointly ...
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 2 hours agoHEALTH NEWS Bristol Myers Squibb said on Friday that its trial evaluating a combination of cancer...
Pancreatic cancer: Symptoms, causes and treatment
The Telegraph via Yahoo News· 1 day agoAs one of the world’s leading experts in pancreatic cancer, Prof Andrew Biankin is all too familiar with the aura of dread which surrounds the disease.
Earnings call: Lisata Therapeutics reports Q1 progress on cancer drug
Investing.com· 18 hours agoLisata Therapeutics (ticker not provided) has reported significant advancements in its first quarter...
S3 Episode 4: Antibody-Drug Conjugates and Lung Cancer
Medscape· 2 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
Macrogenics Stock Drops 77% After Study Deaths
The Wall Street Journal· 3 hours agoMacroGenics shares plunged 77.4% on Friday, erasing $773.2 million in market value, after the biotech reported late Thursday that five patients died in a...
